Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis

Circulation

Volumn 103, Issue 20, 2001, Pages 2453-2460

  Pinede, Laurent ^a,b   Ninet, Jacques ^a   Duhaut, Pierre ^a   Chabaud, Sylvie ^a   Demolombe Rague, Sylvie ^a   Durieu, Isabelle ^a   Nony, Patrice ^a   Sanson, Christian ^a   Boissel, Jean Pierre ^a  

^a HOSPICES CIVILS DE LYON   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Anticoagulants; Pulmonary embolism; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT OUTCOME;

EID: 0035933195     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.20.2453     Document Type: Article

References (23)

1. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals
2. Management of venous thromboembolism
3. Antithrombotic therapy for venous thromboembolic disease
4. Optimal duration of oral anticoagulant therapy following deep vein thrombosis of lower limbs
5. Oral anticoagulation in venous thromboembolism: Decisions based on more than mere feelings
6. The long term clinical course of acute deep venous thrombosis
7. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism
8. Optimum duration of anticoagulation for deep vein thrombosis and pulmonary embolism
9. Optimal duration of oral anticoagulant therapy: A randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis
10. Duration of anticoagulant therapy in venous thromboembolism
11. One-month versus six months therapy with oral anticoagulants after symptomatic deep vein thrombosis
12. The duration of oral anticoagulation after deep vein thrombosis: A randomised study
13. A comparison of 3 and 6 weeks anticoagulation in the treatment of venous thromboembolism
14. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
15. Hemorrhagic complications of anticoagulant treatment
16. Bleeding complications of oral anticoagulant treatment: An inception cohort prospective collaboration study
17. Bleeding complications in oral anticoagulant therapy: An analysis of risk factors
18. Anticoagulant related bleeding: Clinical epidemiology, prediction, and prevention
19. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
20. Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral anticoagulation
21. Deep vein thrombosis and the incidence of subsequent symptomatic cancer
22. Three-months compared with one-year of oral anticoagulant treatment after a first idiopathic deep vein thrombosis: The WODIT trial
23. Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: A meta-analysis of randomised controlled trials